Edward J. Rapp - Jun 30, 2022 Form 4 Insider Report for AbbVie Inc. (ABBV)

Role
Director
Signature
Steven L. Scrogham, attorney-in-fact for Edward J. Rapp
Stock symbol
ABBV
Transactions as of
Jun 30, 2022
Transactions value $
$36,299
Form type
4
Date filed
7/5/2022, 05:23 PM
Previous filing
May 9, 2022
Next filing
Aug 5, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ABBV Stock Equivalent Units Award $36.3K +237 +1.07% $153.16 22.3K Jun 30, 2022 Common Stock 237 $153.16 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock.
F2 Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.